Vitamin C in Severe Sepsis Treatment
A new study reported in the journal CHEST demonstrates the beneficial effects of high-dose intravenous vitamin C in reducing mortality in patients with severe sepsis. However, an Editorial published in the same issue of CHEST, calls for more studies to determine optimal dose of vitamin C in the critically ill population.
See Also: Albumin Administration in Sepsis: The Case for and Against
In the study by Marik et al., 47 subsequent patients with a primary diagnosis of severe sepsis or septic shock were compared to a control cohort in the seven months before. The study intervention included a four-day course of intravenous vitamin C (1.5 g q6h) and intravenous thiamine (200 mg q12h) as well as intravenous hydrocortisone (50 mg q6h). During the control period 60% of patients also received intravenous hydrocortisone (50 mg q6h), but no supplemental vitamin C or thiamine. The study cocktail was administered within 24 hours of ICU admission.
Results showed that hospital mortality was significantly lower in the treatment (8.5%) than in the control group (40.4%). The propensity adjusted odds ratio of mortality in the study patients was 0.13 (95% CI 0.04-0.48). The duration of vasopressor support was reduced by two thirds, the 72 hours delta SOFA score by 82% and the need of renal replacement therapy declined from 37% to 10%. None of the patients in the treatment group developed progressive organ failure.
"The pathophysiology of sepsis reminds us that high-dose intravenous vitamin C should probably be limited to the very early phase of severe sepsis or septic shock, because in the long run low levels of ROS [reactive oxygen species] are crucial for intracellular signalling. To avoid the Linus Pauling trap, pragmatic multicentre trials are needed to confirm this benefit and to exclude unforeseen harm as was seen in previous sepsis trials using promising drugs," write Heleen M. Oudemans-van Straaten, MD, PhD, Paul W.G. Elbers, MD, PhD and Angélique M.E. Spoelstra-de Man, MD, PhD, all from VU University Medical Center in Amsterdam, in the Editorial.
Hydrocortisone and vitamin C act synergistically on multiple sites in the inflammatory cascade, the VUmc doctors explain. In addition, hydrocortisone facilitates the uptake of vitamin C into the cell by restoring the cytokine induced downregulation of the vitamin C transporter, while vitamin C restores the sensitivity of the glucocorticoid receptor. Thiamine was added to reduce the risk of renal oxalate crystallisation.
During sepsis, ROS are produced in neutrophils. ROS do not only kill invading microorganisms but also cause collateral damage to host cells. The authors describe the important role vitamin C plays during lipid oxidation: "Vitamin C is the only antioxidant in plasma able to completely prevent neutrophil induced lipid oxidation. Vitamin C also prevents the depletion of other circulatory antioxidants such as lipid-soluble vitamin E and glutathione, while this is not the case vice versa. However, due to consumption plasma vitamin C becomes rapidly depleted upon neutrophil activation. Early intravenous supplementation is therefore needed to limit oxidation of lipids, proteins and DNA."
The optimal dose of vitamin C in the critically ill population is not known, and pharmacokinetic data in critically ill patients are scarce, the authors point out. In a phase I safety trial in patients with sepsis, high plasma concentrations were associated with an earlier decline in SOFA score and procalcitonin concentrations. With continuous infusion, urinary vitamin C loss and oxalate excretion seem to be lower, while a higher proportion of vitamin C remains in the body. Beneficial effects on organ dysfunction or length of ICU support were reported with intravenous doses between 1 g to up to 200 mg/kg per day. "The concomitant use of hydrocortisone was generally not mentioned. Altogether, dose finding is needed," the authors write.
More studies are needed to determine vitamin C optimal dose and treatment duration in critically ill patients, they add.
Image Credit: Pixabay
Published on : Mon, 17 Apr 2017
Dual-lumen Jejunal Feeding Tube with Integrated Gastric Drainage Clinical Performance Compat Stayput is designed to be able to be placed using a variety of placement techniques at/or beyond the Ligament of Treitz. Nurse Convenience...
Intended for uncomplicated, atraumatic endotracheal tube exchange. Features and benefits The blunt, soft, and flexible tip of the catheter is atraumatic to internal structures. The distal section of the catheter is flexible. The extra-firm...
Designed for many applications. Venue is a multi-purpose, point of care system that is also well-suited to help you manage patients in shock. It includes automated tools that enable you to quickly get the information you need to make fast decisions...
Always in sight, always in mind Features Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands....